The Hydration Pharmaceuticals Company Limited (HPC.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.72 Million | -9.75 Million | -8.07 Million | -3.86 Million | -2.78 Million | -5.39 Million |
| Net Income | -8.1 Million | -10.6 Million | -8.95 Million | -743.66 Thousand | -3.43 Million | -9.6 Million |
| Depreciation & Amortization | - | - | 3337.00 | 23.48 Thousand | 11.72 Thousand | 77.17 Thousand |
| Deferred income taxes | - | - | -945.86 Thousand | 833.53 Thousand | -813.74 Thousand | - |
| Stock-based compensation | 1.03 Million | 1.71 Million | 1.39 Million | 75.13 Thousand | 177.54 Thousand | 61.22 Thousand |
| Change in working capital | 412.86 Thousand | -2.01 Million | -447.19 Thousand | -1.28 Million | 697.87 Thousand | -2.8 Million |
| Other non-cash items | 926.28 Thousand | 1.15 Million | 870.27 Thousand | -1.92 Million | -234.29 Thousand | 6.87 Million |
| Investing Cash Flow | - | - | -2151.00 | 2.73 Million | -20.47 Thousand | - |
| Investments in PPE | - | - | - | -18.07 Thousand | -20.47 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 2.75 Million | - | - |
| Financing Cash Flow | 2.71 Million | 4.07 Million | 17.02 Million | - | 3.04 Million | - |
| Debt repayment | - | -4.07 Million | -8.84 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -241.36 Thousand | - | - | - | - | - |
| Common Stock Issuance | 2.95 Million | - | 12.03 Million | - | - | - |
| Other Financing Activities | 2.71 Million | 4.07 Million | 4.99 Million | - | 3.04 Million | - |
| Accounts receivables | -437.71 Thousand | -293.85 Thousand | -237.95 Thousand | -191.96 Thousand | -81.96 Thousand | -1.02 Million |
| Accounts payables | - | -667.03 Thousand | 1.4 Million | - | - | - |
| Inventory | 851.15 Thousand | -1.72 Million | -209.23 Thousand | -716.69 Thousand | 718.16 Thousand | -1.69 Million |
| Other working capital | -578.00 | 667.03 Thousand | -1.4 Million | -380.96 Thousand | 61.67 Thousand | -82.57 Thousand |
| Cash at beginning of period | 4.68 Million | 10.67 Million | 1.64 Million | 2.73 Million | 2.53 Million | 7.96 Million |
| Cash at end of period | 1.84 Million | 4.68 Million | 10.67 Million | 1.64 Million | 2.73 Million | 2.53 Million |
| Capital Expenditure | - | - | - | -18.07 Thousand | -20.47 Thousand | - |
| Effect of forex changes on cash | 166.19 Thousand | -308.34 Thousand | 80.97 Thousand | 38.92 Thousand | -40.81 Thousand | -34.71 Thousand |
| Net cash flow / Change in cash | -2.84 Million | -5.98 Million | 9.02 Million | -1.09 Million | 200.08 Thousand | -5.43 Million |
| Free Cash Flow | -5.72 Million | -9.75 Million | -8.07 Million | -3.88 Million | -2.8 Million | -5.39 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.55 Million | -1.55 Million | -2.28 Million | -8.1 Million | -2.28 Million | -1.76 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 516.76 Thousand | 1.03 Million | 516.76 Thousand | - |
| Change in working capital | - | - | 206.43 Thousand | 412.86 Thousand | 206.43 Thousand | - |
| Other non-cash items | 509.96 Thousand | 509.96 Thousand | 151.2 Thousand | 926.28 Thousand | 151.2 Thousand | 311.93 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 542.85 Thousand | 542.85 Thousand | 1.36 Million | 2.71 Million | 1.36 Million | -2665.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -241.36 Thousand | - | - |
| Common Stock Issuance | - | - | - | 2.95 Million | - | - |
| Other Financing Activities | 542.85 Thousand | 542.85 Thousand | 1.36 Million | 2.71 Million | 1.36 Million | -2665.00 |
| Accounts receivables | - | - | -218.85 Thousand | -437.71 Thousand | -218.85 Thousand | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | 425.57 Thousand | 851.15 Thousand | 425.57 Thousand | - |
| Other working capital | - | - | -289.00 | -578.00 | -289.00 | - |
| Cash at beginning of period | - | - | - | 4.68 Million | - | - |
| Cash at end of period | -493.15 Thousand | -493.15 Thousand | 50.42 Thousand | 1.84 Million | 50.42 Thousand | -1.47 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 9836.00 | 9836.00 | 101.19 Thousand | 166.19 Thousand | 101.19 Thousand | -18.09 Thousand |
| Net cash flow / Change in cash | -493.15 Thousand | -493.15 Thousand | 50.42 Thousand | -2.84 Million | 50.42 Thousand | -1.47 Million |
| Free Cash Flow | -1.04 Million | -1.04 Million | -1.41 Million | -5.72 Million | -1.41 Million | -1.45 Million |
IPPE
1705
FRPT
8006
SARVESHWAR
B4B